United States Healthcare Equipment & Supplies

Procept Biorobotics Corp (PRCT)

Track

Over the last 90 days, Procept Biorobotics Corp. saw a net insider buying value of $10.13 million, with total buy transactions amounting to $10.48 million and sell transactions at $1.23 million. Executive net transactions were negative at -$351,088. Notable recent transactions include significant planned and proposed sales by Nouri Alaleh and Kevin Waters.
Stock chart
Ticker: PRCT Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Nouri Alaleh
EVP, CLO, CORP. SEC.
2 sales — total 139,231 USD
Planned sale 19 Mar 2026
Value US$4,170,079.63 | Price 17.26 | Shares 58,800
Planned sale 19 Mar 2026
Value US$3,380,489.32 | Price 361.86 | Shares 70,096
Proposed sale 19 Mar 2026
Value US$4,791,688.55 | Price 143.51 | Shares 96,448
Sale 17 Mar 2026
Value US$8,558.57 | Price 28.15 | Shares 304
Proposed sale 17 Mar 2026
Value US$8,558.57 | Price 28.15 | Shares 304
Sale 17 Mar 2026
Value US$19,876.16 | Price 28.15 | Shares 706
Proposed sale 17 Mar 2026
Value US$19,876.16 | Price 28.15 | Shares 706
Planned sale 10 Mar 2026
Value US$3,877.00 | Price 26.74 | Shares 145
Planned sale 10 Mar 2026
Value US$3,877.00 | Price 26.74 | Shares 145
Planned sale 10 Mar 2026
Value US$79,320.26 | Price 25.60 | Shares 3,098
Planned sale 10 Mar 2026
Value US$79,320.26 | Price 25.60 | Shares 3,098
Proposed sale 10 Mar 2026
Value US$81,918.00 | Price 25.26 | Shares 3,243
Buy 9 Mar 2026
Value US$33,042.49 | Price 25.42 | Shares 1,300
Buy 9 Mar 2026
Value US$1,340,348.05 | Price 24.91 | Shares 53,818
Buy 9 Mar 2026
Value US$1,049,500.21 | Price 24.08 | Shares 43,581
Buy 6 Mar 2026
Value US$1,295,790.45 | Price 24.10 | Shares 53,763
Buy 6 Mar 2026
Value US$2,485,713.02 | Price 23.33 | Shares 106,554
Sale 6 Mar 2026
Value US$163,353.49 | Price 23.70 | Shares 6,892
Proposed sale 6 Mar 2026
Value US$163,353.49 | Price 23.70 | Shares 6,892
Sale 6 Mar 2026
Value US$159,300.47 | Price 23.70 | Shares 6,721
Proposed sale 6 Mar 2026
Value US$159,300.47 | Price 23.70 | Shares 6,721
Buy 5 Mar 2026
Value US$653,527.86 | Price 26.41 | Shares 24,748
Buy 5 Mar 2026
Value US$3,625,020.87 | Price 25.44 | Shares 142,498
Buy 13 Aug 2025
Value US$785,138.00 | Price 39.26 | Shares 20,000
Planned sale 12 Jun 2025
Value US$314,692.56 | Price 62.33 | Shares 5,049
Planned sale 12 Jun 2025
Value US$1,222,563.36 | Price 61.28 | Shares 19,951
Planned sale 11 Jun 2025
Value US$367,447.03 | Price 64.27 | Shares 5,717
Planned sale 11 Jun 2025
Value US$729,602.59 | Price 63.47 | Shares 11,495
Planned sale 11 Jun 2025
Value US$487,475.84 | Price 62.59 | Shares 7,788
Planned sale 10 Jun 2025
Value US$111,625.25 | Price 64.67 | Shares 1,726
Planned sale 10 Jun 2025
Value US$1,178,682.85 | Price 64.02 | Shares 18,412
Planned sale 10 Jun 2025
Value US$307,402.87 | Price 63.23 | Shares 4,862
Proposed sale 6 Jun 2025
Value US$1,282,638.00 | Price 64.13 | Shares 20,000
Sale 6 Jun 2025
Value US$117,631.08 | Price 65.35 | Shares 1,800
Sale 6 Jun 2025
Value US$381,609.76 | Price 64.64 | Shares 5,904
Sale 6 Jun 2025
Value US$783,396.60 | Price 63.71 | Shares 12,296
Planned sale 5 Jun 2025
Value US$6,673.00 | Price 66.73 | Shares 100
Planned sale 5 Jun 2025
Value US$263,762.00 | Price 65.94 | Shares 4,000
Planned sale 5 Jun 2025
Value US$816,802.02 | Price 65.09 | Shares 12,548
Planned sale 5 Jun 2025
Value US$381,690.39 | Price 64.19 | Shares 5,946
Planned sale 5 Jun 2025
Value US$107,605.78 | Price 63.07 | Shares 1,706
Planned sale 5 Jun 2025
Value US$43,297.03 | Price 61.85 | Shares 700
Planned sale 4 Jun 2025
Value US$528,052.04 | Price 61.40 | Shares 8,600
Planned sale 4 Jun 2025
Value US$997,503.76 | Price 60.82 | Shares 16,400
Planned sale 3 Jun 2025
Value US$93,855.97 | Price 61.83 | Shares 1,518
Planned sale 3 Jun 2025
Value US$710,228.03 | Price 61.22 | Shares 11,602
Planned sale 3 Jun 2025
Value US$595,094.14 | Price 60.23 | Shares 9,880
Planned sale 3 Jun 2025
Value US$65,058.95 | Price 59.14 | Shares 1,100
Planned sale 3 Jun 2025
Value US$52,237.89 | Price 58.04 | Shares 900
Proposed sale 3 Jun 2025
Value US$8,691,000.00 | Price 57.94 | Shares 150,000
Sale 18 Mar 2025
Value US$312,403.50 | Price 57.06 | Shares 5,475
Proposed sale 18 Mar 2025
Value US$312,403.50 | Price 57.06 | Shares 5,475
Sale 18 Mar 2025
Value US$41,824.98 | Price 57.06 | Shares 733
Proposed sale 18 Mar 2025
Value US$41,824.98 | Price 57.06 | Shares 733
Sale 18 Mar 2025
Value US$14,093.82 | Price 57.06 | Shares 247
Proposed sale 18 Mar 2025
Value US$14,093.82 | Price 57.06 | Shares 247
Sale 18 Mar 2025
Value US$18,030.96 | Price 57.06 | Shares 316
Proposed sale 18 Mar 2025
Value US$18,030.96 | Price 57.06 | Shares 316
Sale 6 Mar 2025
Value US$223,229.71 | Price 61.31 | Shares 3,641
Proposed sale 6 Mar 2025
Value US$223,212.00 | Price 61.31 | Shares 3,641
Sale 6 Mar 2025
Value US$219,980.28 | Price 61.31 | Shares 3,588
Proposed sale 6 Mar 2025
Value US$219,963.00 | Price 61.31 | Shares 3,588
Sale 6 Mar 2025
Value US$224,517.22 | Price 61.31 | Shares 3,662
Proposed sale 6 Mar 2025
Value US$224,500.00 | Price 61.31 | Shares 3,662
Sale 6 Mar 2025
Value US$975,809.96 | Price 61.31 | Shares 15,916
Proposed sale 6 Mar 2025
Value US$975,735.00 | Price 61.31 | Shares 15,916
Planned sale 4 Dec 2024
Value US$221,359.32 | Price 99.04 | Shares 2,235
Planned sale 4 Dec 2024
Value US$502,807.80 | Price 98.09 | Shares 5,126
Planned sale 4 Dec 2024
Value US$1,335,065.38 | Price 97.01 | Shares 13,762
Planned sale 4 Dec 2024
Value US$509,611.96 | Price 96.15 | Shares 5,300
Planned sale 4 Dec 2024
Value US$794,752.20 | Price 97.90 | Shares 8,118
Planned sale 4 Dec 2024
Value US$1,569,815.26 | Price 96.98 | Shares 16,187
Planned sale 4 Dec 2024
Value US$364,006.44 | Price 96.12 | Shares 3,787
Proposed sale 4 Dec 2024
Value US$5,489,275.00 | Price 97.70 | Shares 56,185
Proposed sale 4 Dec 2024
Value US$2,549,291.04 | Price 96.48 | Shares 26,423
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-19 2026-03-19 PlS Planned sale
2.5
Nouri Alaleh

EVP, CLO, CORP. SEC.

Officer
58,800 -2.1%
17.26
US$4,170,080 		58,800 -2.1% 17.26 US$4,170,080
2026-03-19 2026-03-19 PlS Planned sale
2.5
Nouri Alaleh

EVP, CLO, CORP. SEC.

Officer
70,096 +2.6%
361.86
US$3,380,489 		70,096 +2.6% 361.86 US$3,380,489
2026-03-19 2026-03-19 PrS Proposed sale
2.5
Alalah Nouri

Officer

Officer
96,448
143.51
US$4,791,689 		96,448 143.51 US$4,791,689
2026-03-19 2026-03-17 S Sale
2.5
Nouri Alaleh

EVP, CLO, CORP. SEC.

Officer
304 -0.3%
28.15
US$8,559 		304 -0.3% 28.15 US$8,559
2026-03-19 2026-03-17 S Sale
3.1
Waters Kevin

EVP, CFO

Officer
706 -0.5%
28.15
US$19,876 		706 -0.5% 28.15 US$19,876
2026-03-17 2026-03-17 PrS Proposed sale
2.5
Nouri Alaleh

Officer

Officer
304
28.15
US$8,559 		304 28.15 US$8,559
2026-03-17 2026-03-17 PrS Proposed sale
3.1
Waters Kevin

Officer

Officer
706
28.15
US$19,876 		706 28.15 US$19,876
2026-03-12 2026-03-10 PlS Planned sale
2.5
Nouri Alaleh

EVP, CLO, CORP. SEC.

Officer
145 -0.1%
26.74
US$3,877 		145 -0.1% 26.74 US$3,877
2026-03-12 2026-03-10 PlS Planned sale
2.5
Nouri Alaleh

EVP, CLO, CORP. SEC.

Officer
145 -0.1%
26.74
US$3,877 		145 -0.1% 26.74 US$3,877
2026-03-12 2026-03-10 PlS Planned sale
2.5
Nouri Alaleh

EVP, CLO, CORP. SEC.

Officer
3,098 -2.7%
25.60
US$79,320 		3,098 -2.7% 25.60 US$79,320
2026-03-12 2026-03-10 PlS Planned sale
2.5
Nouri Alaleh

EVP, CLO, CORP. SEC.

Officer
3,098 -2.7%
25.60
US$79,320 		3,098 -2.7% 25.60 US$79,320
2026-03-10 2026-03-10 PrS Proposed sale
2.5
Alalah Nouri

Officer

Officer
3,243
25.26
US$81,918 		3,243 25.26 US$81,918
2026-03-09 2026-03-09 B Purchase
Desai Antal Rohit
Non-Executive Director
1,300 +0.3%
25.42
US$33,042 		1,300 +0.3% 25.42 US$33,042
2026-03-09 2026-03-09 B Purchase
Desai Antal Rohit
Non-Executive Director
53,818 +14.5%
24.91
US$1,340,348 		53,818 +14.5% 24.91 US$1,340,348
2026-03-09 2026-03-09 B Purchase
Desai Antal Rohit
Non-Executive Director
43,581 +13.3%
24.08
US$1,049,500 		43,581 +13.3% 24.08 US$1,049,500
2026-03-09 2026-03-06 B Purchase
Desai Antal Rohit
Non-Executive Director
53,763 +19.6%
24.10
US$1,295,790 		53,763 +19.6% 24.10 US$1,295,790
2026-03-09 2026-03-06 B Purchase
Desai Antal Rohit
Non-Executive Director
106,554 +63.7%
23.33
US$2,485,713 		106,554 +63.7% 23.33 US$2,485,713
2026-03-09 2026-03-06 S Sale
2.5
Nouri Alaleh

EVP, CLO, CORP. SEC.

Officer
6,892 -5.7%
23.70
US$163,353 		6,892 -5.7% 23.70 US$163,353
2026-03-09 2026-03-06 S Sale
3.1
Waters Kevin

EVP, CFO

Officer
6,721 -4.2%
23.70
US$159,300 		6,721 -4.2% 23.70 US$159,300
2026-03-06 2026-03-06 PrS Proposed sale
2.5
Nouri Alaleh

Officer

Officer
6,892
23.70
US$163,353 		6,892 23.70 US$163,353
2026-03-06 2026-03-06 PrS Proposed sale
3.1
Waters Kevin

Officer

Officer
6,721
23.70
US$159,300 		6,721 23.70 US$159,300
2026-03-09 2026-03-05 B Purchase
Desai Antal Rohit
Non-Executive Director
24,748 +17.4%
26.41
US$653,528 		24,748 +17.4% 26.41 US$653,528
2026-03-09 2026-03-05 B Purchase
Desai Antal Rohit
Non-Executive Director
142,498 +inf%
25.44
US$3,625,021 		142,498 +inf% 25.44 US$3,625,021
2025-08-14 2025-08-13 B Purchase
1.6
MOLL FREDERIC H
Non-Executive Director
20,000 +2.4%
39.26
US$785,138 		20,000 +2.4% 39.26 US$785,138
2025-06-12 2025-06-12 PlS Planned sale
Desai Antal Rohit
Non-Executive Director
5,049 -26.0%
62.33
US$314,693 		5,049 -26.0% 62.33 US$314,693
2025-06-12 2025-06-12 PlS Planned sale
Desai Antal Rohit
Non-Executive Director
19,951 -50.7%
61.28
US$1,222,563 		19,951 -50.7% 61.28 US$1,222,563
2025-06-12 2025-06-11 PlS Planned sale
Desai Antal Rohit
Non-Executive Director
5,717 -12.7%
64.27
US$367,447 		5,717 -12.7% 64.27 US$367,447
2025-06-12 2025-06-11 PlS Planned sale
Desai Antal Rohit
Non-Executive Director
11,495 -20.3%
63.47
US$729,603 		11,495 -20.3% 63.47 US$729,603
2025-06-12 2025-06-11 PlS Planned sale
Desai Antal Rohit
Non-Executive Director
7,788 -12.1%
62.59
US$487,476 		7,788 -12.1% 62.59 US$487,476
2025-06-12 2025-06-10 PlS Planned sale
Desai Antal Rohit
Non-Executive Director
1,726 -2.6%
64.67
US$111,625 		1,726 -2.6% 64.67 US$111,625
2025-06-12 2025-06-10 PlS Planned sale
Desai Antal Rohit
Non-Executive Director
18,412 -21.8%
64.02
US$1,178,683 		18,412 -21.8% 64.02 US$1,178,683
2025-06-12 2025-06-10 PlS Planned sale
Desai Antal Rohit
Non-Executive Director
4,862 -5.4%
63.23
US$307,403 		4,862 -5.4% 63.23 US$307,403
2025-06-06 2025-06-06 PrS Proposed sale
3.9
SHAM SHIBLAQ

Officer; Director

Executive Director
20,000
64.13
US$1,282,638 		20,000 64.13 US$1,282,638
2025-06-06 2025-06-06 S Sale
3.9
Shiblaq Hisham

EVP, Chief Comm. Officer

Officer
1,800 -2.8%
65.35
US$117,631 		1,800 -2.8% 65.35 US$117,631
2025-06-06 2025-06-06 S Sale
3.9
Shiblaq Hisham

EVP, Chief Comm. Officer

Officer
5,904 -8.3%
64.64
US$381,610 		5,904 -8.3% 64.64 US$381,610
2025-06-06 2025-06-06 S Sale
3.9
Shiblaq Hisham

EVP, Chief Comm. Officer

Officer
12,296 -14.8%
63.71
US$783,397 		12,296 -14.8% 63.71 US$783,397
2025-06-05 2025-06-05 PlS Planned sale
Desai Antal Rohit
Non-Executive Director
100 -0.1%
66.73
US$6,673 		100 -0.1% 66.73 US$6,673
2025-06-05 2025-06-05 PlS Planned sale
Desai Antal Rohit
Non-Executive Director
4,000 -4.3%
65.94
US$263,762 		4,000 -4.3% 65.94 US$263,762
2025-06-05 2025-06-05 PlS Planned sale
Desai Antal Rohit
Non-Executive Director
12,548 -11.8%
65.09
US$816,802 		12,548 -11.8% 65.09 US$816,802
2025-06-05 2025-06-05 PlS Planned sale
Desai Antal Rohit
Non-Executive Director
5,946 -5.3%
64.19
US$381,690 		5,946 -5.3% 64.19 US$381,690
2025-06-05 2025-06-05 PlS Planned sale
Desai Antal Rohit
Non-Executive Director
1,706 -1.5%
63.07
US$107,606 		1,706 -1.5% 63.07 US$107,606
2025-06-05 2025-06-05 PlS Planned sale
Desai Antal Rohit
Non-Executive Director
700 -0.6%
61.85
US$43,297 		700 -0.6% 61.85 US$43,297
2025-06-05 2025-06-04 PlS Planned sale
Desai Antal Rohit
Non-Executive Director
8,600 -7.0%
61.40
US$528,052 		8,600 -7.0% 61.40 US$528,052
2025-06-05 2025-06-04 PlS Planned sale
Desai Antal Rohit
Non-Executive Director
16,400 -11.8%
60.82
US$997,504 		16,400 -11.8% 60.82 US$997,504
2025-06-05 2025-06-03 PlS Planned sale
Desai Antal Rohit
Non-Executive Director
1,518 -1.1%
61.83
US$93,856 		1,518 -1.1% 61.83 US$93,856
2025-06-05 2025-06-03 PlS Planned sale
Desai Antal Rohit
Non-Executive Director
11,602 -7.6%
61.22
US$710,228 		11,602 -7.6% 61.22 US$710,228
2025-06-05 2025-06-03 PlS Planned sale
Desai Antal Rohit
Non-Executive Director
9,880 -6.1%
60.23
US$595,094 		9,880 -6.1% 60.23 US$595,094
2025-06-05 2025-06-03 PlS Planned sale
Desai Antal Rohit
Non-Executive Director
1,100 -0.7%
59.14
US$65,059 		1,100 -0.7% 59.14 US$65,059
2025-06-05 2025-06-03 PlS Planned sale
Desai Antal Rohit
Non-Executive Director
900 -0.5%
58.04
US$52,238 		900 -0.5% 58.04 US$52,238
2025-06-03 2025-06-03 PrS Proposed sale
222 DNA TRUST

Director

Non-Executive Director
150,000
57.94
US$8,691,000 		150,000 57.94 US$8,691,000
2025-03-19 2025-03-18 S Sale
3.3
Zadno Reza

President, CEO

Executive Director
5,475 -3.1%
57.06
US$312,404 		5,475 -3.1% 57.06 US$312,404
2025-03-19 2025-03-18 S Sale
3.1
Waters Kevin

EVP, CFO

Officer
733 -0.7%
57.06
US$41,825 		733 -0.7% 57.06 US$41,825
2025-03-19 2025-03-18 S Sale
3.9
Shiblaq Hisham

EVP, Chief Comm. Officer

Officer
247 -0.4%
57.06
US$14,094 		247 -0.4% 57.06 US$14,094
2025-03-19 2025-03-18 S Sale
2.5
Nouri Alaleh

EVP, CLO, CORP. SEC.

Officer
316 -0.5%
57.06
US$18,031 		316 -0.5% 57.06 US$18,031
2025-03-18 2025-03-18 PrS Proposed sale
3.3
Zadno Reza

Officer; Director

Executive Director
5,475
57.06
US$312,404 		5,475 57.06 US$312,404
2025-03-18 2025-03-18 PrS Proposed sale
3.1
Waters Kevin

Officer

Officer
733
57.06
US$41,825 		733 57.06 US$41,825
2025-03-18 2025-03-18 PrS Proposed sale
3.9
Shiblaq Hisham

Officer

Officer
247
57.06
US$14,094 		247 57.06 US$14,094
2025-03-18 2025-03-18 PrS Proposed sale
2.5
Nouri Alaleh

Officer

Officer
316
57.06
US$18,031 		316 57.06 US$18,031
2025-03-10 2025-03-06 S Sale
2.5
Nouri Alaleh

EVP, CLO, CORP. SEC.

Officer
3,641 -5.6%
61.31
US$223,230 		3,641 -5.6% 61.31 US$223,230
2025-03-10 2025-03-06 S Sale
3.9
Shiblaq Hisham

EVP, Chief Comm. Officer

Officer
3,588 -5.4%
61.31
US$219,980 		3,588 -5.4% 61.31 US$219,980
2025-03-10 2025-03-06 S Sale
3.1
Waters Kevin

EVP, CFO

Officer
3,662 -3.3%
61.31
US$224,517 		3,662 -3.3% 61.31 US$224,517
2025-03-10 2025-03-06 S Sale
3.3
Zadno Reza

President, CEO

Executive Director
15,916 -8.2%
61.31
US$975,810 		15,916 -8.2% 61.31 US$975,810
2025-03-06 2025-03-06 PrS Proposed sale
3.3
Zadno Reza

Officer

Officer
15,916
61.31
US$975,735 		15,916 61.31 US$975,735
2025-03-06 2025-03-06 PrS Proposed sale
3.1
Waters Kevin

Officer

Officer
3,662
61.31
US$224,500 		3,662 61.31 US$224,500
2025-03-06 2025-03-06 PrS Proposed sale
3.9
Shiblaq Hisham

Officer

Officer
3,588
61.31
US$219,963 		3,588 61.31 US$219,963
2025-03-06 2025-03-06 PrS Proposed sale
2.5
Nouri Alaleh

Officer

Officer
3,641
61.31
US$223,212 		3,641 61.31 US$223,212
2024-12-06 2024-12-04 PlS Planned sale
3.3
Zadno Reza

President, CEO

Executive Director
2,235 -1.4%
99.04
US$221,359 		2,235 -1.4% 99.04 US$221,359
2024-12-06 2024-12-04 PlS Planned sale
3.3
Zadno Reza

President, CEO

Executive Director
5,126 -3.2%
98.09
US$502,808 		5,126 -3.2% 98.09 US$502,808
2024-12-06 2024-12-04 PlS Planned sale
3.3
Zadno Reza

President, CEO

Executive Director
13,762 -7.9%
97.01
US$1,335,065 		13,762 -7.9% 97.01 US$1,335,065
2024-12-06 2024-12-04 PlS Planned sale
3.3
Zadno Reza

President, CEO

Executive Director
5,300 -3.0%
96.15
US$509,612 		5,300 -3.0% 96.15 US$509,612
2024-12-06 2024-12-04 PlS Planned sale
2.5
Nouri Alaleh

EVP, CLO, CORP. SEC.

Officer
8,118 -13.4%
97.90
US$794,752 		8,118 -13.4% 97.90 US$794,752
2024-12-06 2024-12-04 PlS Planned sale
2.5
Nouri Alaleh

EVP, CLO, CORP. SEC.

Officer
16,187 -21.1%
96.98
US$1,569,815 		16,187 -21.1% 96.98 US$1,569,815
2024-12-06 2024-12-04 PlS Planned sale
2.5
Nouri Alaleh

EVP, CLO, CORP. SEC.

Officer
3,787 -4.7%
96.12
US$364,006 		3,787 -4.7% 96.12 US$364,006
2024-12-04 2024-12-04 PrS Proposed sale
2.5
Alalah Nouri

Officer

Officer
56,185
97.70
US$5,489,275 		56,185 97.70 US$5,489,275
2024-12-04 2024-12-04 PrS Proposed sale
3.3
REZA ZADNO

Director; Officer

Executive Director
26,423
96.48
US$2,549,291 		26,423 96.48 US$2,549,291
Explore more

More insider trading research around Procept Biorobotics Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America